Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of Nutritional Status at Diagnosis and Weight Changes in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Dominic Brauer, Donata Backhaus, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD PhD, Uwe Platzbecker, Madlen Jentzsch, MD, Sebastian Schwind, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-134187

Published: 2020

Journal Articles

Clinical Relevance of Morphologic and Molecular Complete Remission in AML Patients Undergoing Reduced Intensity or Non-Myeloablative Conditioning

Madlen Jentzsch, MD, Dominic Brauer, Juliane Grimm, MD, Marius Bill, MD PhD, Donata Backhaus, MD, Julia Schulz, Dietger Niederweiser, MD, Uwe Platzbecker, Sebastian Schwind, MD

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-134102

Published: 2020

Journal Articles

The Prognostic Impact of the Diagnostic CD34+/CD38- Cell Burden and Expression of the Stem Cell Marker GPR56 after Stem Cell Transplantation Depends on the AML Origin

Madlen Jentzsch, MD, Marius Bill, MD PhD, Juliane Grimm, MD, Dominic Brauer, MD, Julia Schulz, Karoline Goldmann, Dietger Niederwieser, MD, Uwe Platzbecker, Sebastian Schwind, MD

Blood (2019) 134 (Supplement_1): 323.

https://doi.org/10.1182/blood-2019-127544

Published: 2019

Journal Articles

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Blood (2019) 134 (Supplement_1): 1358.

https://doi.org/10.1182/blood-2019-125262

Published: 2019

Journal Articles

Genome-Wide Association Study (GWAS) Identifies a Significant Acute Myeloid Leukemia (AML) Susceptibility Locus Near BICRA

Blood (2018) 132 (Supplement 1): 85.

https://doi.org/10.1182/blood-2018-99-115170

Published: 2018

Journal Articles

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Vladan Vucinic, MD, Sabine Leiblein, PhD, Kristina Schakols, MD, Claudia Nehring, MD, Yvonne Remane, PhD, Madlen Jentzsch, MD, Sebastian Schwind, MD, Wolfram Pönisch, MD, Runa Stiegler, MD, Constanze Kliem, MD, Michael Cross, PhD, Dietger Niederwieser, MD

Blood (2018) 132 (Supplement 1): 2064.

https://doi.org/10.1182/blood-2018-99-118531

Published: 2018

Journal Articles

Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning — Results of a Prospective Phase II Study. Eudract #: 2007-002420-15

Vladan Vucinic, Saskia Hell, Madlen Jentzsch, MD, Michael Cross, PhD, Sabine Leiblein, Wolfram Pönisch, MD, Georg-Nikolaus Franke, MD, Gerhard Behre, MD, Thoralf Lange, MD, Sebastian Schwind, MD, Dietger Niederwieser, MD

Blood (2017) 130 (Supplement 1): 3230.

https://doi.org/10.1182/blood.V130.Suppl_1.3230.3230

Published: 2017

Journal Articles

MiR-143 Targets ERK5 in Granulopoiesis and Predicts Outcome of Patients with Acute Myeloid Leukemia

Jens-Uwe Hartmann, MSc, Daniela Bräuer-Hartmann, PhD, Miroslava Kardosova, MSc, Franziska Wilke, MSc, Alexander Arthur Wurm, PhD, Cindy Schoedel, MD, Dennis Gerloff, PhD, Christiane Katzerke, PhD, Rosanna H.E. Krakowsky, MSc, Carolina Yaeko Namasu, MSc, Marius Bill, Sebastian Schwind, MD, Carsten Müller-Tidow, Dietger W. Niederwieser, MD, Meritxell Alberich-Jorda, Gerhard Behre, MD

Blood (2017) 130 (Supplement 1): 3950.

https://doi.org/10.1182/blood.V130.Suppl_1.3950.3950

Published: 2017

Journal Articles

Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission

Juliane Grimm, Marius Bill, PhD, Madlen Jentzsch, MD, Stefanie Beinicke, MSc, Janine Häntschel, MSc, Karoline Goldmann, Julia Schulz, Michael Cross, PhD, Wolfram Pönisch, MD, Vladan Vucinic, Gerhard Behre, MD, Thoralf Lange, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 406.

https://doi.org/10.1182/blood.V130.Suppl_1.406.406

Published: 2017

Journal Articles

In AML RAS pathway Mutations Confer Worse Outcome in IDH1 and IDH2 Mutated AML Patients Receiving Hematopoietic Stem Cell Transplantation

Stefanie Beinicke, MSc, Juliane Grimm, Madlen Jentzsch, MD, Marius Bill, PhD, Janine Häntschel, MSc, Karoline Goldmann, Julia Schulz, Michael Cross, PhD, Georg-Nikolaus Franke, MD, Vladan Vucinic, Wolfram Pönisch, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 2037.

https://doi.org/10.1182/blood.V130.Suppl_1.2037.2037

Published: 2017

Journal Articles

High Expression of the DNMT3A Embedded Pri- Mir -1301 Associates with Improved Outcome in Patients with Acute Myeloid Leukemia

Janine Häntschel, MSc, Madlen Jentzsch, MD, Juliane Grimm, Marius Bill, Stefanie Beinicke, MSc, Laura K. Schmalbrock, MD, Lynn Bonifacio, MD, Luba Schuhmann, Julia Schulz, Karoline Goldmann, Michael Cross, PhD, Georg-Nikolaus Franke, MD, Vladan Vucinic, Wolfram Pönisch, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 1203.

https://doi.org/10.1182/blood.V130.Suppl_1.1203.1203

Published: 2017

Journal Articles

CCND1 and CCND2 Mutations Are Frequent in Adults with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) with t(8;21)(q22;q22)

Ann-Kathrin Eisfeld, MD, Jessica Kohlschmidt, PhD BS, MS, Sebastian Schwind, MD, Deedra Nicolet, James S. Blachly, MD, Shelley Orwick, BS, Chandni Shah, Maryam Bainazar, Karl Kroll, Christopher J Walker, Andrew J. Carroll, PhD, Bayard L Powell, MD, Richard M. Stone, MD, Jonathan E. Kolitz, MD, Maria R. Baer, MD, Albert de la Chapelle, Krzysztof Mrózek, MD PhD, John C. Byrd, MD, Clara D. Bloomfield, MD

Blood (2016) 128 (22): 2740.

https://doi.org/10.1182/blood.V128.22.2740.2740

Published: 2016

Journal Articles

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Blood (2016) 128 (22): 1066.

https://doi.org/10.1182/blood.V128.22.1066.1066

Published: 2016

Journal Articles

High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia

Madlen Jentzsch, MD, Marius Bill, MDPhD, Julia Schulz, Juliane Grimm, Stefanie Beinicke, Karoline Schubert, Janine Haentschel, Kathrin Wildenberger, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 517.

https://doi.org/10.1182/blood.V128.22.517.517

Published: 2016

Journal Articles

High Expression of ZBTB7A at Diagnosis Associated with Inferior Outcome in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation

Juliane Grimm, Madlen Jentzsch, MD, Marius Bill, MD PhD, Julia Schulz, Karoline Schubert, Stefanie Beinicke, Janine Haentschel, Luba Schuhmann, Michael Cross, PhD, Vladan Vucinic, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 5092.

https://doi.org/10.1182/blood.V128.22.5092.5092

Published: 2016

Journal Articles

Biological Associations and Clinical Impact of Differential Expression of the Pre- Mir-29a/b-1 and P re -Mir-29b-2/C Clusters in Acute Myeloid Leukemia

Florian Ramdohr, MD, Marius Bill, MD PhD, Madlen Jentzsch, MD, Karoline Schubert, Juliane Grimm, Julia Schulz, Luba Schuhmann, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Stefanie Beinicke, Janine Haentschel, Wolfram Poenisch, MD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Thoralf Lange, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 5110.

https://doi.org/10.1182/blood.V128.22.5110.5110

Published: 2016

Journal Articles

Absolute Quantification of Pre- microRNA-155 Copy Numbers By Digital Droplet PCR Identifies Acute Myeloid Leukemia (AML) Patients with Adverse Outcome

Marius Bill, MD PhD, Madlen Jentzsch, MD, Julia Schulz, Karoline Schubert, Juliane Grimm, Laura Katharina Schmalbrock, MD, Lynn Baquiran Bonifacio, MD, Stefanie Beinicke, Janine Haentschel, Wolfram Poenisch, MD, Gerhard Behre, MD, Vladan Vucinic, MD, Thoralf Lange, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2016) 128 (22): 1698.

https://doi.org/10.1182/blood.V128.22.1698.1698

Published: 2016

Journal Articles

High Expression of the Hedgehog Transcription Factor GLI1 Is Associated with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Non-Myeloablative Conditioning

Marius Bill, MDPhD, Madlen Jentzsch, MD, Luba Schuhmann, Juliane Grimm, Maria Knyrim, Laura Katharina Schmalbrock, MD, Schubert Karoline, Michael Cross, PhD, Vladan Vucinic, MD, Georg-Nikolaus Franke, MD, Wolfram Poenisch, MD, Gerhard Behre, MD, Thoralf Lange, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 2032.

https://doi.org/10.1182/blood.V126.23.2032.2032

Published: 2015

Journal Articles

Next Generation Sequencing and Functional Analysis of Mirna Expression in Acute Myeloid Leukemia Patients with Different FLT3 Mutations: Block of MiR-155 in FLT3-ITD Driven AML Leads to Downregulation of Myeloid Blasts in Vivo

Dennis Gerloff, Alexander Arthur Wurm, Jens-Uwe Hartmann, Nadja Hilger, Anne-Marie Müller, Christiane Katzerke, PhD, Daniela Bräuer-Hartmann, Carolina Yaeko Namasu, MSc, Michael Cross, PhD, Sebastian Schwind, MD, Knut Krohn, PhD, Stephan Fricke, MD, Dietger Niederwieser, MD, Gerhard Behre, MD

Blood (2015) 126 (23): 2438.

https://doi.org/10.1182/blood.V126.23.2438.2438

Published: 2015

Journal Articles

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Madlen Jentzsch, MD, Luba Schuhmann, Marius Bill, MDPhD, Sabine Leiblein, PhD, Ulrike Bergmann, Martina Pless, Karoline Schubert, Laura Katharina Schmalbrock, MD, Juliane Grimm, Maria Knyrim, Wolfram Poenisch, MD, Georg-Nikolaus Franke, MD, Vladan Vucinic, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 2573.

https://doi.org/10.1182/blood.V126.23.2573.2573

Published: 2015

NARROW

Prognostic Impact of Nutritional Status at Diagnosis and Weight Changes in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Relevance of Morphologic and Molecular Complete Remission in AML Patients Undergoing Reduced Intensity or Non-Myeloablative Conditioning

The Prognostic Impact of the Diagnostic CD34+/CD38- Cell Burden and Expression of the Stem Cell Marker GPR56 after Stem Cell Transplantation Depends on the AML Origin

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Genome-Wide Association Study (GWAS) Identifies a Significant Acute Myeloid Leukemia (AML) Susceptibility Locus Near BICRA

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning — Results of a Prospective Phase II Study. Eudract #: 2007-002420-15

MiR-143 Targets ERK5 in Granulopoiesis and Predicts Outcome of Patients with Acute Myeloid Leukemia

Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission

In AML RAS pathway Mutations Confer Worse Outcome in IDH1 and IDH2 Mutated AML Patients Receiving Hematopoietic Stem Cell Transplantation

High Expression of the DNMT3A Embedded Pri- Mir -1301 Associates with Improved Outcome in Patients with Acute Myeloid Leukemia

CCND1 and CCND2 Mutations Are Frequent in Adults with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) with t(8;21)(q22;q22)

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia

High Expression of ZBTB7A at Diagnosis Associated with Inferior Outcome in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation

Biological Associations and Clinical Impact of Differential Expression of the Pre- Mir-29a/b-1 and P re -Mir-29b-2/C Clusters in Acute Myeloid Leukemia

Absolute Quantification of Pre- microRNA-155 Copy Numbers By Digital Droplet PCR Identifies Acute Myeloid Leukemia (AML) Patients with Adverse Outcome

High Expression of the Hedgehog Transcription Factor GLI1 Is Associated with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Non-Myeloablative Conditioning

Next Generation Sequencing and Functional Analysis of Mirna Expression in Acute Myeloid Leukemia Patients with Different FLT3 Mutations: Block of MiR-155 in FLT3-ITD Driven AML Leads to Downregulation of Myeloid Blasts in Vivo

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only